Nicholas A.j. Botwood

Head of R&D, CMO, Syndax Pharmaceuticals Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 12, 2026Sold 31,235 shares at $18.14 of Syndax Pharmaceuticals Inc²
Jun 12, 2026Exercised options 31,235 shares at $13.82 of Syndax Pharmaceuticals Inc²
Jun 11, 2026Sold 34,280 shares at $18.00 of Syndax Pharmaceuticals Inc²
Jun 11, 2026Exercised options 22,515 shares at $13.82 of Syndax Pharmaceuticals Inc²
Feb 4, 2026Granted 36,000 shares of Syndax Pharmaceuticals Inc³
Feb 4, 2026Granted 24,000 shares of Syndax Pharmaceuticals Inc³
May 16, 2025Bought 11,765 shares at $9.00 of Syndax Pharmaceuticals Inc⁴

The numbers on this page point here. Each one links to the record it came from.